규제 업데이트
FDA, EMA, TGA 및 글로벌 규제 동향
규제 업데이트
2026년 9월 23일•1분 읽기
FDA Approves Multiple Supplemental Applications for LIDOPEN (NDA 017549)
The FDA has granted approval for several supplemental submissions related to LIDOPEN, an injectable lidocaine product now discontinued.
규제 업데이트
2026년 9월 23일•1분 읽기
FDA Approves Labeling Supplements for Discontinued Divalproex Sodium Delayed‑Release Tablets
The FDA records show that three discontinued oral delayed‑release tablet products of Divalproex Sodium (125 mg, 250 mg, 500 mg) received approved labeling supplemental submissions.
규제 업데이트
2026년 9월 23일•1분 읽기
Korean Health & Welfare Committee Submits 376 Agenda Items Including Pharmacy Act Amendment
The National Assembly’s Health and Welfare Committee presented 376 items—371 bills and 5 petitions—covering health, food‑medicine, and disease control, with a key Pharmacy Act amendment addressing warehouse‑type pharmacies.
규제 업데이트
2026년 9월 23일•1분 읽기
Korean Pharmacists Association Calls for Withdrawal of Remote Prescription Day Limit and Drug Delivery Expansion
The Korean Pharmacists Association urges the government to scrap the 7‑day limit on first‑time telemedicine prescriptions and the planned expansion of drug delivery, citing patient safety.
규제 업데이트
2026년 9월 23일•1분 읽기
Cook Medical Alerts: Female Luer Lock Adapter May Be Misaligned in Certain Device Lots
Cook Medical reports that certain device lots may have a misaligned female luer lock adapter due to manufacturing errors.
규제 업데이트
2026년 9월 23일•1분 읽기
Cook Medical alerts on potential manufacturing defect in cystoscopic injection needle
Cook Medical reports that certain cystoscopic injection needle lots may have a misaligned female luer lock adapter.
규제 업데이트
2026년 9월 23일•1분 읽기
Health Canada Issues Alert on 3930M Transvenous DF4 Cardiac Lead Adhesive Issue
Health Canada alerts that the 3930M transvenous DF4 cardiac lead may suffer driveshaft separation due to insufficient adhesive bonding, potentially leading to lead fracture.
규제 업데이트
2026년 9월 23일•1분 읽기
Health Canada Alert: IMAAVY Lots May Contain Glass Particles
Health Canada warns that IMAAVY solution lots JNYJ1202 and JNYJ1206 may contain glass particles; recall limited to healthcare establishments.
규제 업데이트
2026년 9월 23일•1분 읽기
Health Canada alerts on model 3930M transvenous DF4 lead adhesive bond issue
Health Canada identified inadequate adhesive coverage in the model 3930M DF4 transvenous lead, which can cause helix separation and potential lead fracture.
규제 업데이트
2026년 9월 23일•1분 읽기
GC Green Cross Advances mRNA COVID-19 Vaccine GC4006A to Phase 2 Trial
GC Green Cross secured MFDS IND approval for its mRNA COVID‑19 vaccine candidate GC4006A and will begin a Phase 2 study in Korea targeting adults 19‑85, aiming for domestic self‑sufficiency by 2028.
규제 업데이트
2026년 9월 23일•1분 읽기
B. Braun reports PIL errors in Meropenem 1000 mg infusion product
B. Braun Melsungen AG has informed the MHRA of patient information leaflet errors in certain Meropenem 1000 mg powder and solvent batches.
규제 업데이트
2026년 9월 23일•1분 읽기
Pharmacists' Association Holds 357th Day Relay Protest Demanding Regulatory Reform for Han‑yak Pharmacists
The Korean Pharmacists' Association staged its 357th consecutive relay protest in front of the Blue House, urging the government and National Assembly to clarify licensing scopes and resolve role conflicts between pharmacists and han‑yak (traditional medicine) pharmacists.